Fund Holdings — Squadron Capital Management LLC

Total Portfolio Value:
$337.42M
Total Bought:
$337.42M
Total Sold:
$0
Net Transaction:
+$337.42M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Kodiak Sciences Inc.(KOD)0420,000+420,000$0$39.82M11.80%+$39.82M
C4 Therapeutics Inc09,318,683+9,318,683$0$31.03M9.20%+$31.03M
Cogent Biosciences, Inc.(COGT)0915,000+915,000$0$29.30M8.68%+$29.30M
Silence Therapeutics plcADS(SLN)02,085,000+2,085,000$0$22.79M6.75%+$22.79M
Zentalis Pharmaceuticals Inc06,827,905+6,827,905$0$18.91M5.61%+$18.91M
Edgewise Therapeutics, Inc.(EWTX)0425,000+425,000$0$17.25M5.11%+$17.25M
Relay Therapeutics, Inc.(RLAY)0785,000+785,000$0$14.17M4.20%+$14.17M
Oric Pharmaceuticals Inc01,000,000+1,000,000$0$13.47M3.99%+$13.47M
Relmada Therapeutics Inc03,500,000+3,500,000$0$13.20M3.91%+$13.20M
Definium Therapeutics, Inc.(DFTX)0340,000+340,000$0$12.94M3.84%+$12.94M
Pharvaris N.V.(PHVS)0400,000+400,000$0$12.69M3.76%+$12.69M
Adlai Nortye Group LtdADS0764,876+764,876$0$12.24M3.63%+$12.24M
Vera Therapeutics, Inc.CL A(VERA)0305,000+305,000$0$9.85M2.92%+$9.85M
Inventiva SaADS02,400,000+2,400,000$0$8.86M2.62%+$8.86M
Avalo Therapeutics Inc0450,000+450,000$0$6.90M2.04%+$6.90M
Aclaris Therapeutics Inc01,200,000+1,200,000$0$6.31M1.87%+$6.31M
Assembly Biosciences Inc0225,000+225,000$0$5.29M1.57%+$5.29M
Adagene IncADS01,616,618+1,616,618$0$5.17M1.53%+$5.17M
Crescent Biopharma Inc.0350,000+350,000$0$5.11M1.51%+$5.11M
Yarrow Bioscience Inc0225,000+225,000$0$5.07M1.50%+$5.07M
Zura Bio LtdCL A01,200,000+1,200,000$0$4.99M1.48%+$4.99M
Tcgx Acquisition CorpCL A0370,220+370,220$0$4.63M1.37%+$4.63M
Contineum Therapeutics IncCL A0323,570+323,570$0$4.34M1.29%+$4.34M
Inhibikase Therapeutics Inc02,000,000+2,000,000$0$4.11M1.22%+$4.11M
Palisade Bio Inc03,000,000+3,000,000$0$4.05M1.20%+$4.05M
Tango Therapeutics, Inc.(TNGX)0150,000+150,000$0$3.74M1.11%+$3.74M
Janux Therapeutics Inc0215,000+215,000$0$3.72M1.10%+$3.72M
Savara Inc.(SVRA)0675,000+675,000$0$3.48M1.03%+$3.48M
Quince Therapeutics Inc090,000+90,000$0$2.79M0.83%+$2.79M
Jatt Iii Acquisition Corp0250,000+250,000$0$2.75M0.82%+$2.75M
Scynexis Inc0515,045+515,045$0$2.54M0.75%+$2.54M
Alx Oncology Hldgs Inc01,400,000+1,400,000$0$1.95M0.58%+$1.95M
Lipocine Inc New0810,000+810,000$0$1.78M0.53%+$1.78M
Pepgen Inc0600,000+600,000$0$1.45M0.43%+$1.45M
Jatt Ii Acquisition Corp065,000+65,000$0$730.9K0.22%+$730.9K
Page 1 of 1